Navigation Links
RECITAL Study Presents Excellent Outcomes and Rapid Patient Recovery With Revolutionary Femoral Access Procedure
Date:12/1/2011

ore comfortable experience for the patient while reducing hospital resource use and overall cost per patient.

Separately, Arstasis announced the appointment of David I. Bruce to the position of President and CEO. The company's founder, Bruce Modesitt, who has been CEO since its inception in 2004, will focus on expanding the product platform as Chief Technology Officer.

"At this point in our company's history, we're delighted to attract a seasoned CEO with repeat successes in managing early market penetration for novel medical devices," commented Bruce Modesitt, "and I look forward to David's leadership in accelerating our business growth."

New CEO David Bruce said, "I'm pleased to be joining the Arstasis team as we announce the results of our first U.S. clinical trial. RECITAL demonstrates the Arstaotomy procedure helps minimize complications, speed recovery and enable earlier discharge. With our investigators and initial customers showing outstanding results, we are positioned to achieve broader adoption into the ten million arterial catheterization procedures performed worldwide each year."

The AXERA™ Access Device is a breakthrough femoral artery access tool that quickly creates a long, ultra-low angle arteriotomy, the Arstaotomy, resulting in significant tissue-upon-tissue overlap in the artery wall. The Arstaotomy procedure requires minimal manual compression to provide secure arterial closure with no foreign body implants thereby eliminating the risk of infections and thromboembolic events related to vascular implants.

Arstasis, Inc. is headquartered in Redwood City, CA. Additional information about the RECITAL Study, Arstaotomy procedure and AXERA Access Device is available at www.arstasis.com.

CONTACT:
Mark Page
Sr. Director, Marketing
Arstasis, Inc.
650-508-1549


'/>"/>
SOURCE Arstasis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
2. Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinsons Disease
3. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
4. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
5. New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System
6. Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1
7. Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist
8. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
9. Perceptive Informatics® Global Survey Results Indicate Wide Use of Industry-Standard Medical Imaging Metrics to Meet Study Milestones
10. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
11. goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...  EndoChoice Holdings, Inc. (NYSE:  GI) announced today that ... on Thursday, August 6, 2015 before the market open. ... on Thursday, August 6, 2015 at 9:00 a.m. ET ... 807-9684 for domestic callers and (412) 317-5415 for international ... be available on the investor relations section of the ...
(Date:7/6/2015)... 2015  OrthoSpace Ltd. ("OrthoSpace" or "Company") announced ... in its US Investigational Device Exemption (IDE) pivotal ... single blinded control study that compares the Company,s ... partial repair for the treatment of full thickness ... commercially available outside of the United ...
(Date:7/6/2015)... - The Canadian Pharmacists Association (CPhA) urges the federal government ... all Canadians have the opportunity to protect themselves against ... The lack of access to HPV vaccination programs for ... needlessly putting the health of Canadians at risk. ... pose a significant threat to the health of Canadians," ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2OrthoSpace Enrolls First Patients in US IDE Study 2CPhA Calls for HPV Strategy for Young Men to Save Lives 2
... MiMedx Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer ... processed from human amniotic membrane, announced today its results ... 30, 2011. The Company recorded record revenue ... over second quarter of 2011 revenue of $1,929,000 and ...
... Oct. 26, 2011 Reportlinker.com ... research report is available in ... Early Stage Drug Safety Strategies ... towards achieving clinical success ...
Cached Medicine Technology:MiMedx Group Announces Third Quarter 2011 Results 2MiMedx Group Announces Third Quarter 2011 Results 3MiMedx Group Announces Third Quarter 2011 Results 4MiMedx Group Announces Third Quarter 2011 Results 5MiMedx Group Announces Third Quarter 2011 Results 6MiMedx Group Announces Third Quarter 2011 Results 7MiMedx Group Announces Third Quarter 2011 Results 8MiMedx Group Announces Third Quarter 2011 Results 9MiMedx Group Announces Third Quarter 2011 Results 10Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 2Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 3Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 4Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 5Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 6Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 7Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 8
(Date:7/7/2015)... ... , ... Dr. Poneh Ghasri , cosmetic dentist in Los Angeles, is ... one of the fastest, easiest ways to brighten a smile. Stained teeth can add ... confidence. With the right teeth whitening treatment, patients can restore a more youthful appearance ...
(Date:7/7/2015)... ... 2015 , ... Office Practicum announced today that it has ... effective July 6th, 2015. Ellen joins Office Practicum with more than 27 years ... chemical company to early and growth-stage technology companies. , Purdy joins Office ...
(Date:7/7/2015)... ... July 07, 2015 , ... ISI ... announced the release of Service Pack 5600 for its Call Accounting and ... enhancements to the already robust capabilities of the reporting platform, including updates ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Connexion Point is holding an onsite job ... be held at 1769 Paragon Place, Suite 100, this upcoming Wednesday, July 8, and Thursday, ... fair, Connexion Point will be recruiting new applicants as well as holding onsite interviews. ...
(Date:7/6/2015)... Angeles, CA (PRWEB) , ... July 06, 2015 , ... ... for finding medical providers for personal injury victims. Throughout the company’s history the ... collectively deliver the care victims need in their recovery. And while Doctors on ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:Office Practicum Announces new CFO 2Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3
... April 30 Retirement Living TV (RLTV) ... to bring a compelling,dialogue on the healthcare ... Virginia and Southern Delaware television markets through ... The nation,s leading,political and public leaders present ...
... April 30 Brown & Toland Medical Group,today announced ... of $12 million on total revenues of $235 million., ... million for,pay for performance and other related bonuses from ... distribute an additional $8.2,million in bonus payments to eligible ...
... study finds antidepressant cut inflammation in relapsing remitting ... may help reduce disease activity in people with the ... study suggests. , Forty patients with the disease were ... of fluoxetine (Prozac) or a placebo for 24 weeks. ...
... in heart rate variability, researchers report, , , WEDNESDAY, April ... show that the electromagnetic field produced by incubators affect ... , Whether these changes in cardiac rhythms have long-term ... premature infants who can spend several weeks or months ...
... during its Q1 2008 ... conference call on May 8 -, ... the "Company") (NASDAQ: SXCI , TSX: SXC), a leading provider,of ... (NASDAQ: NMHC ), announce that the previously,announced acquisition of NMHC ...
... to Both Reduce Exacerbations ... and Improve Lung Function, ... and Drug Administration today approved Advair Diskus(R) 250/50,(fluticasone propionate 250 ... exacerbations in patients with chronic obstructive,pulmonary disease (COPD) who have ...
Cached Medicine News:Health News:Retirement Living TV Partners with Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare '08: Search for Solutions 2Health News:Retirement Living TV Partners with Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare '08: Search for Solutions 3Health News:Brown & Toland Announces 2007 Financial Results 2Health News:Prozac Reduces Disease Activity in MS Patients 2Health News:Incubators Affect Newborns' Heart Rates 2Health News:SXC Health Solutions completes acquisition of NMHC 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 3Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 4
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance....
The Smart Check Syphilis Device is a qualitative membrane device based immunoassay for the detection of TP (Treponema Pallidum) antibodies in whole blood/serum/plasma. For professional in vitro diagn...
Bio-Quant, Inc. OneStep hCG InstaTest is an immunochromatographic assay designed for qualitative determination of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy....
OneStep Midstream Urine hCG Pregnancy InstaTest is a test kit for the determination of hCG(Human Chorionic Gonadotropin) in urine specimens. This test kit is used to obtain a visual, qualitative resu...
Medicine Products: